Skip to main content
Top

Clinical & Experimental Metastasis

Issue 8/2005

Content (13 Articles)

Review

Roles for neuregulins in human cancer

Christophe Stove, Marc Bracke

Syngeneic lymph-node-targeting model of green fluorescent protein-expressing Lewis lung carcinoma

Vladimir Bobek, Katarina Kolostova, Daniela Pinterov, Michael Boubelik, Ping Jiang, Meng Yang, Robert M. Hoffman

Caffeine suppresses metastasis in a transgenic mouse model: a prototype molecule for prophylaxis of metastasis

Haiyan Yang, Jessica Rouse, Luanne Lukes, Mindy Lancaster, Timothy Veenstra, Ming Zhou, Ying Shi, Yeong-Gwan Park, Kent Hunter

Association of α v β 3 integrin expression with the metastatic potential and migratory and chemotactic ability of human osteosarcoma cells

Xiaoping Duan, Shu-Fang Jia, Zhichao Zhou, Robert R. Langley, Marcela F. Bolontrade, Eugenie S. Kleinerman

A high expression level of insulin-like growth factor I receptor is associated with increased expression of transcription factor Sp1 and regional lymph node metastasis of human gastric cancer

Yixing Jiang, Liwei Wang, Weida Gong, Daoyan Wei, Xiangdong Le, James Yao, Jaffer Ajani, James L. Abbruzzese, Suyun Huang, Keping Xie

Acknowledgements

Acknowledgements

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine